Form 8-K CVS HEALTH Corp For: Feb 09
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/21/2026
- Nasdaq leads Wall Street gains as SpaceX, Super Micro boost AI sentiment
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
- SpaceX, Tesla shares rise after Musk says committees exploring possible merger
- Brent falls as Iran's president discusses mediation with Pakistani army chief
- Abbott plans to spin off its nutrition unit as a standalone public company
- Alphabet shares drop ahead of earnings next week
- Supermicro raises Q1 FY2027 revenue outlook on AI demand
- Dow outperforms as Wall Street rises, healthcare stocks lead gains
- Nasdaq leads Wall Street gains as SpaceX, Super Micro boost AI sentiment
FBR Still Impressed with CVS Health (CVS) Following Inline Q4 Results; Affirms at 'Outperform'
February 9, 2016 2:34 PM ESTFBR & Co. reaffirms its Outperform rating and $120 price target on CVS Health (NYSE: CVS) following the retail pharmacy giant's Q4 report earlier Tuesday.
Analyst Steven Halper noted that revenue increased 11 percent and was inline with expectations, as was the company's quarterly... More



